Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2
Introduction 8
2.1 What Is This Report About? 8
3 Definitions of the
Markets Covered in the Report 9
3.1 Drug delivery devices 9
3.2
Inhalation Systems 9
3.2.1 Metered Dose Inhaler 9
3.2.2 Dry powder
inhaler 9
3.3 Infusion Systems 9
3.3.1 Infusion pumps 9
3.3.2
Syringe pumps 9
3.3.3 Disposable Infusion sets 10
4 Healthcare Sector
Review 11
5 Regulation System 12
5.1 Approval Process 12
5.2
Registration Procedures 13
5.3 Registration of Class I, Class IIa and
Class IIb devices at DPPC 13
5.4 Declaration of Conformity (Self
certification) 14
5.5 Free Sale Certificate 14
5.6 CE Certificate
15
6 Pricing and Reimbursement 16
7 Distribution Structure 17
8
Drug Delivery Devices In Egypt 18
8.1 Drug Delivery Devices Cross Country
Comparison (2000-2012) 18
8.2 Drug Delivery Devices, Egypt, Overall
Revenues ($ mn), 2000-2012 19
8.3 Drug Delivery Devices, Egypt, Category
Volume (Units), 2000-2012 23
8.4 Drug Delivery Devices, Egypt Company
share (2006-2007) 26
9 Infusion Systems In Egypt 27
9.1 Infusion
Systems Overall Revenue (2000-2012) 27
9.2 Infusion Systems Overall Volume
(2000-2012) 29
9.3 Infusion Systems Average Price (2000-2012) 30
9.4
Infusion Systems Distribution Share (2006-2007) 30
9.5 Infusion Systems,
Egypt, Company Share (2006-2007) 31
10 Inhalation Systems In Egypt 32
10.1 Inhalation Systems Overall Revenue (2000-2012) 32
10.2 Inhalation
Systems Overall Volume (2000-2012) 34
10.3 Inhalation Systems Average
Price (2000-2012) 36
10.4 Inhalation Systems Distribution Share
(2006-2007) 36
10.5 Inhalation Systems, Egypt, Company Share (2006-2007)
37
11 AstraZeneca PLC Company Profile 38
11.1 Company Overview 38
12 GlaxoSmithKline plc Company Profile 39
12.1 Company Overview 39
13
3M Company Company Profile 40
13.1 Company Overview 40
13.2 Value
Chain Analysis 40
13.2.1 Manufacturing 41
13.2.2 Product Development
41
13.2.3 Sales and Marketing 41
14 Novartis Medical Nutrition Company
Profile 43
14.1 Company Overview 43
15 Cardinal Health, Inc. Company
Profile 44
15.1 Company Overview 44
15.2 Value Chain Analysis 44
15.2.1 Manufacturing 45
15.2.2 Product Development 45
15.2.3 Sales and
Marketing 46
16 Baxter International Inc. Company Profile 47
16.1
Company Overview 47
16.2 Value Chain Analysis 47
16.2.1 Manufacturing
48
16.2.2 Product Development 48
16.2.3 Sales and Marketing 49
16.2.4 Baxter International Inc. Pipeline Products by Equipment Type 49
16.2.5 Baxter International Inc. Pipeline Products by Development Stage 49
16.2.6 Baxter International Inc. Pipeline Products by Therapy Area 50
16.2.7 Baxter International Inc. Pipeline Products by News Summary 50
17
Appendix 51
17.1 Global Markets Direct Research Methodology 51
17.2
Coverage 52
17.3 Secondary Research 52
17.4 Primary Research 53
17.5 Models 53
17.6 Forecasts 54
17.7 Expert Panels 54
17.8
Currency Conversion 55
17.9 Contact Us 56
17.10 Disclaimer 56
1.1 List of Tables
Table 1: Drug Delivery Devices Cross Country
Comparison (2000-2012) 18
Table 2: Drug Delivery Devices, Egypt,
Overall Revenues ($ mn), 2000-2012 19
Table 3: Drug Delivery Devices,
Egypt, Portfolio Analysis, 2000-2012 20
Table 4: Drug Delivery
Devices, Egypt, Overall Revenues ($ mn), Historic, 2000-2007 21
Table 5:
Drug Delivery Devices, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012
22
Table 6: Drug Delivery Devices, Egypt, Category Volume (Units),
2000-2012 23
Table 7: Drug Delivery Devices, Egypt, Category Volume
(Units), Historic, 2000-2007 24
Table 8: Drug Delivery Devices,
Egypt, Category Volume (Units), Forecast, 2007-2012 25
Table 9: Drug
Delivery Devices, Egypt Company share by Revenue ($ mn), 2006-2007 26
Table 10: Infusion Systems, Egypt, Revenue ($ mn) by Segment, Historic,
2000-2007 27
Table 11: Infusion Systems, Egypt, Revenue ($ mn) by
Segment, Forecast, 2007-2012 28
Table 12: Infusion Systems, Egypt,
Overall Volume (Units), Historic, 2000-2007 29
Table 13: Infusion
Systems, Egypt, Overall Volume (Units), Forecast, 2007-2012 29
Table 14:
Infusion Systems, Egypt, Average Price ($), Historic, 2000-2007 30
Table 15: Infusion Systems, Egypt, Average Price ($), Forecast, 2007-2012
30
Table 16: Infusion Systems, Egypt, Distribution Share by Revenue
($mn), 2006-2007 30
Table 17: Infusion Systems, Egypt, Company Share
by Revenue ($ mn), 2006-2007 31
Table 18: Inhalation Systems, Egypt,
Revenue ($ mn) by Segment, Historic, 2000-2007 32
Table 19:
Inhalation Systems, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012
33
Table 20: Inhalation Systems, Egypt, Overall Volume (Units),
Historic, 2000-2007 34
Table 21: Inhalation Systems, Egypt, Overall
Volume (Units), Forecast, 2007-2012 35
Table 22: Inhalation Systems,
Egypt, Average Price ($), Historic, 2000-2007 36
Table 23: Inhalation
Systems, Egypt, Average Price ($), Forecast, 2007-2012 36
Table 24:
Inhalation Systems, Egypt, Distribution Share by Revenue ($mn), 2006-2007
36
Table 25: Inhalation Systems, Egypt, Company Share by Revenue ($
mn), 2006-2007 37
Table 26: Baxter International Inc. Pipeline
Products by Equipment Type 49
Table 27: Baxter International Inc.
Pipeline Products By Development Stage 49
Table 28: Baxter
International Inc. Pipeline Products By Therapy Area 50
Table 29:
Baxter International Inc. Pipeline Products By News Summaries 50
Table 30:
Currency Conversion from USD to Local Currency at 2007 Constant Rate 55
1.2 List of Figures
Figure 1: Drug Delivery Devices Cross
Country Comparison (2000-2012) 18
Figure 2: Drug Delivery Devices,
Egypt, Overall Revenues ($ mn), 2000-2012 19
Figure 3: Drug Delivery
Devices, Egypt, Portfolio Analysis, 2000-2012 20
Figure 4: Drug
Delivery Devices, Egypt, Overall Revenues ($ mn), Historic, 2000-2007 21
Figure 5: Drug Delivery Devices, Egypt, Overall Revenues ($ mn),
Forecast, 2007-2012 22
Figure 6: Drug Delivery Devices, Egypt,
Category Volume (Units), 2000-2012 23
Figure 7: Drug Delivery
Devices, Egypt, Category Volume (Units), Historic, 2000-2007 24
Figure 8:
Drug Delivery Devices, Egypt, Category Volume (Units), Forecast, 2007-2012
25
Figure 9: Drug Delivery Devices, Egypt Company share (%), 2007
26
Figure 10: Infusion Systems, Egypt, Revenue ($ mn) by Segment,
Historic, 2000-2007 27
Figure 11: Infusion Systems, Egypt, Revenue ($
mn) by Segment, Forecast, 2007-2012 28
Figure 12: Infusion Systems,
Egypt, Company Share (%), 2007 31
Figure 13: Inhalation Systems,
Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 32
Figure 14:
Inhalation Systems, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012
33
Figure 15: Inhalation Systems, Egypt, Overall Volume (Units),
Historic, 2000-2007 34
Figure 16: Inhalation Systems, Egypt, Overall
Volume (Units), Forecast, 2007-2012 35
Figure 17: Inhalation Systems,
Egypt, Company Share (%), 2007 37
Figure 18: 3M Healthcare Value
Chain Analysis 40
Figure 19: Cardinal Health, Inc. Value Chain
Analysis 44
Figure 20: Baxter International Inc. Value Chain Analysis
47
Figure 21: Global Markets Direct Methodology 51
|
Related Report
|
View Cart
